Live Quote · NASDAQLRMRHealthcare· Biotechnology

Larimar Therapeutics, Inc.

$3.14▼ 2.48%($-0.08)
MKT CAP $328.55MNEXT EARNINGS Mar 18, 2027
50%
Bullish
TickerSpark Score
48/100
▌ Weak
70
Valuation
20
Profitability
15
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LRMR research report →

Analyst Price Target
$7.00+122.9% vs. today

Range $5 – $9

Analyst RatingBuy
8 Buy0 Hold0 Sell

Price Chart

-7.20% · this period
$5.95$3.97$1.99Nov 19May 22Nov 19
52-Week Range27% of range
Low
$1.92
Current
$3.14
High
$6.42